Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 6, 2017	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-17-071604.pdf 0001193125-17-071604.rtf 0001193125-17-071604.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000880.pdf 0001562180-17-000880.rtf 0001562180-17-000880.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000878.pdf 0001562180-17-000878.rtf 0001562180-17-000878.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000881.pdf 0001562180-17-000881.rtf 0001562180-17-000881.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000879.pdf 0001562180-17-000879.rtf 0001562180-17-000879.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000882.pdf 0001562180-17-000882.rtf 0001562180-17-000882.xls View HTML
February 23, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-000883.pdf 0001562180-17-000883.rtf 0001562180-17-000883.xls View HTML
February 14, 2017	SC 13G/A	An amendment to the SC 13G filing	0000315066-17-001401.pdf 0000315066-17-001401.rtf View HTML
February 14, 2017	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001144204-17-008617.pdf 0001144204-17-008617.rtf 0001144204-17-008617.xls View HTML
February 14, 2017	UPLOAD	UPLOAD	0000000000-17-005267.pdf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax